[{"address1": "955 Chesterbrook Boulevard", "address2": "Suite 110", "city": "Chesterbrook", "state": "PA", "zip": "19087", "country": "United States", "phone": "610 354 8840", "website": "https://www.trevena.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.", "fullTimeEmployees": 23, "companyOfficers": [{"maxAge": 1, "name": "Ms. Carrie L. Bourdow", "age": 60, "title": "President, CEO & Chairman", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 1083155, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Barry  Shin", "age": 51, "title": "Executive VP, COO & CFO", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 722788, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark A. Demitrack M.D.", "age": 65, "title": "Senior VP & Chief Medical Officer", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 741345, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Howard A. Rockman M.D.", "title": "Scientific Founder, Consultant and Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.45, "open": 5.2, "dayLow": 4.735, "dayHigh": 5.4226, "regularMarketPreviousClose": 4.45, "regularMarketOpen": 5.2, "regularMarketDayLow": 4.735, "regularMarketDayHigh": 5.4226, "beta": 1.017, "forwardPE": -0.24937026, "volume": 47175, "regularMarketVolume": 47175, "averageVolume": 62537, "averageVolume10days": 102690, "averageDailyVolume10Day": 102690, "ask": 5.05, "askSize": 100, "marketCap": 4222018, "fiftyTwoWeekLow": 3.35, "fiftyTwoWeekHigh": 25.75, "priceToSalesTrailing12Months": 9.530515, "fiftyDayAverage": 5.1584, "twoHundredDayAverage": 10.74235, "currency": "USD", "enterpriseValue": 23902552, "floatShares": 844540, "sharesOutstanding": 852933, "sharesShort": 20075, "sharesShortPriorMonth": 899, "sharesShortPreviousMonthDate": 1722384000, "dateShortInterest": 1724976000, "sharesPercentSharesOut": 0.0235, "heldPercentInsiders": 0.007929999, "heldPercentInstitutions": 0.03926, "shortRatio": 0.88, "shortPercentOfFloat": 0.0238, "bookValue": -22.226, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -37027000, "trailingEps": -56.5, "forwardEps": -19.85, "enterpriseToRevenue": 53.956, "enterpriseToEbitda": -0.683, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "TRVN", "underlyingSymbol": "TRVN", "shortName": "Trevena, Inc.", "longName": "Trevena, Inc.", "firstTradeDateEpochUtc": 1391178600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ab31c962-bf5d-3c6b-b3ee-f6b5d965694f", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.95, "targetHighPrice": 125.0, "targetLowPrice": 75.0, "targetMeanPrice": 100.0, "targetMedianPrice": 100.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 16367000, "totalCashPerShare": 19.189, "ebitda": -35009000, "totalDebt": 36474000, "quickRatio": 3.144, "currentRatio": 3.464, "totalRevenue": 443000, "revenuePerShare": 0.612, "returnOnAssets": -0.71509004, "freeCashflow": -20903624, "operatingCashflow": -31514000, "revenueGrowth": -0.892, "grossMargins": -2.71783, "operatingMargins": -20.00923, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-17"}]